Chronic Conditions
What Are the Side Effects of Long-Term Use of Omeprazole?
Long-term use of Omeprazole, particularly for more than 3 months and especially beyond a year, may be associated with uncommon but important risks, including hypomagnesaemia (low magnesium), vitamin B12 deficiency, bone fractures, Clostridioides difficile (C. diff) infection and other effects linked to prolonged stomach acid suppression [1].
Omeprazole is a proton pump inhibitor (PPI) and is one of the most widely used UK medicines for conditions caused by excess stomach acid. It is commonly prescribed for acid reflux, indigestion and GORD (gastro-oesophageal reflux disease), while alternatives such as lansoprazole may also be used. For most people, omeprazole remains a safe and effective treatment. However, some studies have identified uncommon serious side effects that may become more relevant during prolonged treatment.
It is important to understand that many of the reported risks come from observational studies. These studies can identify associations but cannot always prove that omeprazole directly caused a particular problem. This is why healthcare professionals recommend using the appropriate dose, reviewing treatment regularly and ensuring there is a clear reason for ongoing therapy [2].
In One Sentence:
Omeprazole is generally safe, but long-term use may increase the risk of low magnesium, vitamin B12 deficiency, bone fractures and gut infections, so it should be taken at the lowest effective dose with regular review.
Key Takeaways
What counts as long-term use?
Long-term Omeprazole use generally means treatment lasting more than 3 months, while many short-term conditions only require a few weeks of treatment.
Is it safe long-term?
For many people, the benefits versus risks remain favourable, but regular review is important.
What are the main risks?
Potential concerns include low magnesium, vitamin B12 deficiency, bone fractures, gut infections and rarely acute interstitial nephritis (kidney inflammation).
Should I stop if I am worried?
No. Suddenly stopping treatment may cause acid rebound, so speak to a GP or pharmacist first.
What is the golden rule?
Use the lowest effective dose and shortest time possible, with periodic review of whether treatment is still needed.
What qualifies as long-term omeprazole use?
Long-term omeprazole use generally means taking the medicine for more than 3 months, while short-term treatment often lasts between 2 and 4 weeks.
Many people use omeprazole for acute acid reflux, heartburn or indigestion for only a short period. The NHS advises that over-the-counter treatment is generally limited to 2 weeks unless further medical advice is obtained.
Conditions such as Barrett's oesophagus, severe reflux disease, GORD, a peptic or stomach ulcer, eradication treatment for H. pylori infection or stomach protection alongside anti-inflammatory painkillers (NSAIDs) may require longer treatment.
According to NICE guidance, patients receiving long-term PPIs should have their treatment reviewed regularly and, where appropriate, step down to the lowest effective dose for the shortest time [3]. Available strengths include 10mg/20mg/40mg gastro-resistant capsules, with dosing recommendations outlined in UK dosing guidance for omeprazole [4].
Short-term
Short-term treatment usually lasts 2 to 4 weeks and is commonly used for temporary reflux symptoms, indigestion and heartburn.
Long-term
Long-term treatment is often reserved for chronic acid-related conditions where the benefits of ongoing acid suppression outweigh the potential risks.
"Long-term PPI treatment can be entirely appropriate when there is a clear clinical need. The important step is ensuring every patient has a regular medication review so treatment can be reassessed, adjusted or deprescribed where appropriate."
What are the 4 major risks of taking omeprazole long-term?
The main concerns linked with long-term use involve nutrient deficiencies, fractures, infections and rare organ-related complications.
Most people will never experience these problems. However, the risks may become more relevant when higher doses are used for a year or longer. The Medicines and Healthcare products Regulatory Agency (MHRA) has issued several drug safety warnings covering these areas.
1. Nutrient and vitamin deficiencies
Reduced stomach acid may affect the body's ability to absorb certain nutrients.
Hypomagnesaemia (low magnesium)
Long-term stomach acid reduction can occasionally affect nutrient absorption, particularly magnesium. The MHRA warning notes that prolonged PPI treatment may lead to hypomagnesaemia (low magnesium), often after around a year of use [5] [6].
Symptoms can include tiredness, muscle cramps and twitches, tremor and an irregular heartbeat. The MHRA advises considering serum magnesium monitoring before and during long-term treatment, especially in people taking digoxin or diuretics (water tablets).
Iron and calcium absorption may also be affected in some individuals.
Vitamin B12 deficiency
Long-term suppression of stomach acid may interfere with the release of vitamin B12 from food. This process normally depends on adequate acid and intrinsic factor.
Research involving nearly 26,000 patients with vitamin B12 deficiency found an association between prolonged PPI use and increased deficiency risk [7]. Possible symptoms include a sore red tongue, mouth ulcers, pins and needles, fatigue and cognitive changes. Older or malnourished people may be more susceptible.
The NHS also notes that prolonged treatment may affect vitamin B12 and magnesium levels [8].
2. Increased risk of bone fractures
Long-term PPI use has been associated with a modest increase in fracture risk.
Studies have reported slightly higher rates of bone fractures (hip, wrist, spine) in people taking PPIs long-term [9]. Reduced calcium absorption has been proposed as one possible explanation.
The MHRA 2012 safety update highlighted epidemiological evidence suggesting an increased risk among people using high doses for more than a year [10].
Those with osteoporosis, particularly adults over 50, may benefit from ensuring adequate calcium and vitamin D intake and discussing whether a bone health assessment or bone mineral density / DEXA scan is appropriate.
3. Gut and respiratory infections
Reduced stomach acid may weaken one of the body's natural defences against infection.
Normally, stomach acid helps destroy swallowed bacteria before they reach the intestines. Long-term acid suppression may increase the risk of infections including Clostridioides difficile (C. diff), Campylobacter and Salmonella [11].
Symptoms of C. diff may include persistent diarrhoea, abdominal pain and fever. Some studies have also linked PPIs to a higher risk of community-acquired pneumonia, with symptoms such as cough, fever and breathlessness.
Researchers have also explored the effects of PPIs on the gut microbiome, although the clinical significance remains an active area of study.
4. Rare organ complications and other effects
Rare complications involving the kidneys, skin and stomach lining have been reported.
Acute interstitial nephritis
Acute interstitial nephritis (kidney inflammation) is a rare immune-related reaction that can occur with PPI use. A systematic review found associations between PPIs and adverse kidney outcomes, including chronic kidney disease and acute kidney injury [12].
Symptoms may include reduced urination, swelling and unusual tiredness.
Fundic gland polyps
Long-term treatment can sometimes lead to fundic gland polyps (benign stomach lining growths). These are usually harmless and often found incidentally during endoscopy.
Subacute cutaneous lupus erythematosus (SCLE)
The MHRA 2015 update highlighted a very rare risk of subacute cutaneous lupus erythematosus (SCLE) [13]. Symptoms may include a sun-exposed rash and joint pain. Patients affected are advised to seek medical advice and consider sun avoidance.
Long-term treatment may also theoretically contribute to atrophic gastritis in some circumstances. Additionally, acid suppression can sometimes contribute to masking stomach cancer symptoms, which is why the NHS advises reporting any new, persistent or changing symptoms promptly.
Long-term risk | Possible symptoms | When it is more likely |
| Low magnesium (hypomagnesaemia) | Tiredness, muscle cramps, tremor, irregular heartbeat | Usually after about a year, especially with diuretics or digoxin |
| Vitamin B12 deficiency | Fatigue, sore tongue, mouth ulcers, pins and needles | Use beyond a year, older or malnourished people |
| Bone fractures and osteoporosis | Bones that break more easily after a minor fall | High doses for over a year, adults over 50 |
| Gut and chest infections | Persistent diarrhoea (C. diff), cough or fever (pneumonia) | Prolonged acid suppression |
| Rare organ effects | Kidney inflammation, benign stomach polyps, sun-exposed rash | Uncommon, some after a year or more |
Keep the risks in proportion
The potential risks should always be balanced against the benefits of treatment.
PPIs provide effective acid-related symptom control and important stomach protection for many patients. Much of the evidence comes from observational research (association versus proven cause), meaning not every reported risk is definitely caused by omeprazole.
Regular review and use of the lowest effective dose remain the key principles of safe long-term treatment.
Why is stopping omeprazole "cold turkey" a problem? Acid rebound
Stopping omeprazole suddenly can trigger acid rebound hypersecretion.
After two months or more of treatment, the stomach may temporarily produce extra stomach acid when treatment stops. This is known as acid rebound hypersecretion.
Research involving healthy volunteers found that around 40 to 50% developed clinically relevant acid-related symptoms after PPI withdrawal [14]. Symptoms may include reflux or heartburn returning worse than before treatment started.
This occurs because acid suppression increases levels of gastrin, which stimulates parietal cells involved in acid production. Although unpleasant, the effect is usually temporary and settles within weeks.
"Many people mistake rebound symptoms for proof that they still need the medicine permanently. In reality, acid rebound is often a temporary adjustment period that can be managed by stepping treatment down gradually and controlling breakthrough symptoms."
How do you taper off omeprazole safely? The UK approach
Gradual dose reduction is usually the preferred approach when stopping long-term treatment.
Healthcare professionals generally recommend speaking with a GP or pharmacist before making changes. Expert guidance on safely deprescribing PPIs supports reviewing the ongoing need for treatment and recognising acid rebound as a genuine phenomenon [15].
Reduce the dose
A common approach is dose reduction (20mg to 10mg) before stopping completely.
Space out the doses
Some patients benefit from every-other-day dosing for a short period during tapering.
Stop, with a backup
An antacid, alginate such as Gaviscon or an H2 blocker (e.g. famotidine) may help manage breakthrough symptoms while the stomach readjusts.
Review
A prescriber review should assess whether ongoing treatment is still needed. Lifestyle changes, including weight management, reducing late-night meals and limiting trigger foods, may also help. Some patients eventually move to on-demand dosing rather than daily treatment.
The NHS also advises against stopping omeprazole suddenly without guidance.
Lifestyle change | How it helps reflux |
| Eat smaller, more frequent meals | Reduces pressure on the stomach and the valve at the top of it |
| Avoid known trigger foods | Cuts irritation from spicy, fatty or acidic foods |
| Do not eat within 3 hours of bedtime | Lets the stomach empty before you lie down |
| Raise the head of your bed | Uses gravity to help keep acid down overnight |
| Reduce alcohol and caffeine | Both can relax the valve and increase acid |
| Stop smoking | Smoking weakens the valve between the stomach and gullet |
| Lose excess weight around the middle | Lowers abdominal pressure that pushes acid upwards |
How does Mail My Meds help you manage your reflux safely?
Mail My Meds supports safe and appropriate management of reflux medicines through regular review and pharmacy support.
As a regulated online pharmacy, Mail My Meds helps patients access treatment through the NHS Electronic Prescription Service (EPS) and convenient home delivery of repeat NHS prescriptions. The pharmacy team can support regular medication review, confirm the correct dose and encourage prescriber review where appropriate.
This includes discussing whether a PPI is still needed, reviewing long-term treatment plans and helping patients understand available options.
Managing omeprazole with Mail My Meds
Safe treatment involves ensuring every medicine has a clear purpose, an appropriate dose and regular review to maintain the best balance between benefit and risk.
Frequently Asked Questions
What qualifies as long-term use of omeprazole?
Long-term use generally means taking omeprazole for more than 3 months, while short-term use (2 to 4 weeks) is common for acute reflux and heartburn. People with chronic conditions may require longer treatment, but ongoing therapy should undergo periodic review.
Can I stop taking omeprazole cold turkey?
No. Stopping suddenly can cause rebound acid hypersecretion, resulting in extra acid and symptoms returning worse than before. A gradual reduction plan discussed with a GP or pharmacist is usually preferable.
Does long-term omeprazole use cause vitamin deficiencies?
Long-term stomach acid reduction may affect vitamin B12 and magnesium absorption, particularly with use beyond a year. Symptoms may include tiredness, pins and needles and muscle twitches. A blood test can help assess levels where clinically appropriate.
Is long-term omeprazole safe?
For most people, yes. The balance of benefits versus risks remains favourable when there is a clear indication. Serious side effects are uncommon, especially when treatment is used at the lowest effective dose for the shortest time with periodic review.
Should I take magnesium or B12 supplements with omeprazole?
Routine supplements are not recommended for everyone. Decisions about magnesium and B12 checks should be guided by symptoms, blood results and clinical advice.
Can long-term omeprazole cause kidney problems?
Rarely, yes. Acute interstitial nephritis is an uncommon form of kidney inflammation that often improves on stopping the medicine. Symptoms can include reduced urination, swelling and unusual tiredness.
Final Thoughts From Our Superintendent Pharmacist
"Omeprazole remains a safe and effective medicine for many people, even during long-term use when clinically appropriate. Although concerns such as low magnesium, low vitamin B12, weaker bones and gut infections have been highlighted in MHRA warnings and research studies, these remain uncommon serious problems. It is important to remember the difference between association and proven cause when interpreting the evidence. Patients should never stop treatment abruptly because acid rebound can make symptoms temporarily worse. The safest approach is regular review, using the lowest effective dose, making suitable lifestyle changes and discussing any gradual step-down plan with a pharmacist or GP."
Sources
[1] Omeprazole: a medicine to treat heartburn and indigestion - NHS
[3] Dyspepsia - proven GORD | Health topics A to Z | CKS | NICE
[4] Omeprazole | Drugs | BNF | NICE
[5] Proton Pump Inhibitors and Hypomagnesaemia - GOV
[6] Proton pump inhibitors in long-term use: reports of hypomagnesaemia - GOV.UK
[7] Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency - PubMed
[8] Omeprazole: a medicine to treat heartburn and indigestion - NHS
[9] Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies - PMC
[10] PPIs in Long Term Use - GOV
[11] Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors - PMC
[13] Proton pump inhibitors: very low risk of subacute cutaneous lupus erythematosus - GOV.UK
[14] The process of pregnancy resolution among adolescent mothers - PubMed
About the author
Blog author
Dayna Sheppard
Dayna is a pharmacy manager with over 15 years of pharmacy experience. She is focused on delivering a safe and excellent pharmacy service for patients.
Medically reviewed by
Medical reviewer
Taslima Hussain
Taslima is a pharmacist who is passionate about patient care. She has experience working in community pharmacy as a locum.
